Herein, we describe a case of immunotherapy-related autoimmune hemolytic anemia (irAIHA) in a patient with locally advanced mismatch repair-deficiency colorectal cancer treated with toripalimab, a programmed cell death 1 (PD-1) (ICI). The gene discussed is PDCD1; the disease is autoimmune hemolytic anemia.